SSA
ACAD icon

Schonfeld Strategic Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.29M Buy
+199,024
New +$4.29M 0.03% 550
2025
Q1
Sell
-69,169
Closed -$1.27M 2043
2024
Q4
$1.27M Buy
69,169
+30,232
+78% +$555K 0.01% 964
2024
Q3
$599K Sell
38,937
-15,406
-28% -$237K ﹤0.01% 1223
2024
Q2
$883K Sell
54,343
-13,996
-20% -$227K 0.01% 1140
2024
Q1
$1.26M Buy
+68,339
New +$1.26M 0.01% 980
2023
Q4
Sell
-79,700
Closed -$1.66M 1738
2023
Q3
$1.66M Buy
79,700
+5,033
+7% +$105K 0.01% 763
2023
Q2
$1.79M Buy
+74,667
New +$1.79M 0.02% 781
2022
Q2
Sell
-33,900
Closed -$821K 2388
2022
Q1
$821K Buy
+33,900
New +$821K 0.01% 1029
2021
Q4
Sell
-33,200
Closed -$552K 1920
2021
Q3
$552K Sell
33,200
-14,473
-30% -$241K 0.01% 1138
2021
Q2
$1.16M Buy
47,673
+32,271
+210% +$787K 0.01% 842
2021
Q1
$397K Buy
+15,402
New +$397K ﹤0.01% 1184
2020
Q4
Sell
-39,629
Closed -$1.64M 1488
2020
Q3
$1.64M Buy
39,629
+16,676
+73% +$688K 0.03% 534
2020
Q2
$1.11M Buy
+22,953
New +$1.11M 0.03% 540
2020
Q1
Sell
-5,017
Closed -$214K 1096
2019
Q4
$214K Buy
+5,017
New +$214K 0.01% 1144
2019
Q3
Sell
-297,300
Closed -$7.95M 978
2019
Q2
$7.95M Buy
297,300
+202,300
+213% +$5.41M 0.28% 89
2019
Q1
$2.55M Buy
95,000
+13,000
+16% +$349K 0.09% 284
2018
Q4
$1.33M Sell
82,000
-20,900
-20% -$338K 0.05% 407
2018
Q3
$2.14M Buy
102,900
+78,400
+320% +$1.63M 0.09% 270
2018
Q2
$375K Sell
24,500
-78,661
-76% -$1.2M 0.02% 589
2018
Q1
$2.32M Buy
+103,161
New +$2.32M 0.17% 167
2017
Q1
Sell
-26,944
Closed -$777K 576
2016
Q4
$777K Sell
26,944
-9,814
-27% -$283K 0.1% 262
2016
Q3
$1.17M Sell
36,758
-4,210
-10% -$134K 0.2% 146
2016
Q2
$1.33M Buy
40,968
+3,172
+8% +$103K 0.3% 92
2016
Q1
$1.06M Buy
+37,796
New +$1.06M 0.43% 62